DIAXEMET XR, PHARMACOR METFORMIN XR (Pharmacor Pty Ltd)
Product name
DIAXEMET XR, PHARMACOR METFORMIN XR
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
136 working days (255)
Active ingredients
metformin hydrochloride
Registration type
New generic medicine
Indication
DIAXEMET XR, PHARMACOR METFORMIN XR (modified release tablet) is indicated in the treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. DIAXEMET XR, PHARMACOR METFORMIN XR may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.